Enhanced liver fibrosis score predicts transplant‐free survival in primary sclerosing cholangitis

There is a need to determine biomarkers reflecting disease activity and prognosis in primary sclerosing cholangitis (PSC). We evaluated the prognostic utility of the enhanced liver fibrosis (ELF) score in Norwegian PSC patients. Serum samples were available from 305 well‐characterized large‐duct PSC...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology (Baltimore, Md.) Md.), 2015-07, Vol.62 (1), p.188-197
Hauptverfasser:	Vesterhus, Mette, Hov, Johannes Roksund, Holm, Anders, Schrumpf, Erik, Nygård, Ståle, Godang, Kristin, Andersen, Ina Marie, Næss, Sigrid, Thorburn, Douglas, Saffioti, Francesca, Vatn, Morten, Gilja, Odd Helge, Lund‐Johansen, Fridtjof, Syversveen, Trygve, Brabrand, Knut, Parés, Albert, Ponsioen, Cyriel Y., Pinzani, Massimo, Färkkilä, Martti, Moum, Bjørn, Ueland, Thor, Røsjø, Helge, Rosenberg, William, Boberg, Kirsten Muri, Karlsen, Tom H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Case-Control Studies Cholangitis, Sclerosing - mortality Cholangitis, Sclerosing - pathology Clinical outcomes Confidence intervals Female Fibrosis Hepatology Humans Liver - pathology Male Medical prognosis Middle Aged Norway - epidemiology Severity of Illness Index
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!